Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed

Annals of Allergy, Asthma and Immunology

Volumn 76, Issue 2, 1996, Pages 204-208

  Dockhorn, Robert J ^a,c   Williams, Benjamin O ^b   Sanders, Ronald L ^b  

^a IMTCI   (United States)

^b Burroughs Wellcome Co   (United States)

^c IITCI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; HISTAMINE H1 RECEPTOR ANTAGONIST; PLACEBO; PSEUDOEPHEDRINE; RAGWEED ANTIGEN;

ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG MIXTURE; HEADACHE; HEART PALPITATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NERVOUSNESS; NOSE CONGESTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; XEROSTOMIA;

EID: 0030020910     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63423-0     Document Type: Article

References (14)

1. Naclerio RM. Allergic rhinitis. N Engl J Med 1991;325:860-9.
2. Anonymous. Histamine and antihistamines. Drug Evaluations Subscription; Am Med Assoc 1990; Vol. III, Section 16:1-12.
3. 1-receptor antagonists. Ann Allergy 1991;65:5-19.
4. Brogden Rn, McTavish D. Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders. Drugs 1991;41:927-40.
5. Gervais P, Bruttman G, Pedrali P, et al. French multicentre double-blind study to evaluate the efficacy and safety of acrivastine as compared with terfenadine in seasonal allergic rhinitis. J Int Med Res 1989;17:47B-53B.
6. Bojkowski CJ, Gibbs TG, Helstern KH, et al. Acrivastine in allergic rhinitis: a review of clinical experience. J Intern Med Res 1989;17: 54B-68B.
7. van Joost T, Blog FB, Westerhof W, et al. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria. J Intern Med Res 1989;17:14B-7B.
8. Leyh F, Harvey SG, Gibson JR, Manna VK. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idopathic urticaria. J Intern Med Res 1989;17:22B-5B.
9. Marks P, Manna VK, Gibson JR. Acrivastine - an evaluation of initial and peak activity in human skin. J Intern Med Res 1989;17:3B-8B.
10. Callaghan HM, Frosolono MF, Rolan P, Posner J. Onset of effect of products containing acrivastine, loratadine, or clemastine [Abstract]. Ann Allergy 1994;72:82.
11. Frosolono MF, Findlay S, van Bavel J, et al. A comparison of Prolert-D (acrivastine + pseudoephedrin HCl), Seldane, Hismanal, and placebo for treatment of seasonal allergic rhinitis [Abstract]. Ann Allergy 1992;68:112.
12. 1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers. J Intern Med Res 1989;17: 35B-9B.
13. Anonymous. Protection of human subjects and Institutional Review Boards. Code of Federal Regulations 1993;21: 229-45.
14. Williams BO, Hull H, McSorley P, Fosolono MF, Sanders RL. Efficacy of acrivastine + pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar. Ann Allergy, Asthma, & Immunol (in press).